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ENVIRONMENTALLY INDUCED REVERSIBLE PROTEIN
TRANSLOCATION ACROSS INNER MITOCHONDRIAL
MEMBRANE
A. WAKSMAN
Centre de Neurochimie du Centre National de la Recherche Scientifique, 67084 Strasbourg Cedex,
France
Four molecular mechanisms account for protein transloca-
tion across biological membranes: translocation via vecto-
rial translation, via vectorial processing, via subunit disso-
ciation, and via environmental induction. Whereas the
first three mechanisms are vectorial, the last one is revers-
ible (1). Fig. 1 describes the general methodology and
observations that led us to the discovery of this last
mechanism.
RESULTS AND DISCUSSION
Externalization of a protein such as aspartate aminotrans-
ferase (AAT) from the inner face of inner mitochondrial
membrane towards intermembranal fluid is shown in Fig.
1, step 1. This step is induced by movement effectors, e.g.,
succinate, fumarate, malate, pyruvate, citrate, phenylsuc-
cinate, a-methylglutamate, etc., at concentrations ranging
from 0 to 50 mM (2). Step 2 shows internalization of
previously externalized AAT upon removal of the move-
ment effector. This was demonstrated by testing the acces-
sibility of the enzyme protein first on the outer face of the
mitoplast (mitochondria from which the outer membrane
was removed), then on the outer face of the corresponding
inverted vesicle, which is equivalent to the inner face of the
mitoplast (step 3). No permeant substrate, controlled
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FIGURE 1 Environmentally induced aspartate aminotransferase move-
ment within the mitochondria (10% AAT).
protease digestion, and specific antibody were used as
criteria of accessibility. Outer membrane was separated
from mitoplast after incubation of 10 mg mitochondrial
protein with 1 mg digitonin (3). Specific reorganization of
membrane and adjoining subcompartment following expo-
sure to various movement effectors was estimated by
showing: (a) the specific modification of intermembrane
fluid protein patterns provoked by different movement
effectors as revealed by polyacrylamide gel electrophoresis
(2); and (b) the differential localization of AAT in the
mitochondrial compartments in the presence of different
movement effectors (3) (Table I). These results not only
TABLE I
INFLUENCE OF THE NATURE OF MOVEMENT
EFFECTOR ON THE SUBMITOCHONDRIAL
LOCALIZATION OF ASPARTATE AMINOTRANSFERASE
Percent of total aspartate aminotransferase activity
Movement in different submitochondrial compartments
effector Intermembrane Inner
space (fluid) membrane Matrix
Sucrose 9 79 12
Phosphate 19 68 13
Acetate 20.5 72 7.5
Succinate 39 25 36
Fumarate 79 6 15
Oxaloacetate 77.5 11.5 11
Citrate 59.5 1.5 39
Results are expressed as percent of total asparate aminotransferase
activity. Total aspartate aminotransferase was constant to within ±5%.
Sucrose was 0.25 M. Effectors were at 2 imol/mg of mitochondrial
protein.
confirm the specific action of effectors and repartition of
membrane and perimembrane protein, but also demon-
strate externalization. Inner membrane was separated
from matrix after incubation of 1 mg mitoplast protein
with 0.16 mg Lubrol WX.
This protein movement is dependent (4) on membrane
fluidity and on temperature. The richer the membrane in
polyunsaturated fatty acids, the lower the temperature of
the break of the Arrhenius curve accounting for the
movement effector induced protein externalization. In the
case of the two populations of brain mitochondria (cell
body and synaptosomal), when the ratio of saturated to
polyunsaturated fatty acids varies from 1.07 to 0.62 the
temperature of the break of the Arrhenius curve for AAT
externalization varies from 270C to 1 50C.
Studies on the temperature-dependent movement of
AAT in structurally intact mitochondria were performed
by measuring reversible loss of AAT latency in the
presence of 1.8 mM succinate using nonpermeant NADH
at various temperatures (1, 3).
The results confirmed that AAT-reversible movements
TABLE II
DRIVING FORCE FOR PROTEIN MOVEMENT
Possible nature Results Conclusions
Energy-rich intermediate No inhibition of reversible movement by antimycin A, rotenone, oligomycin, 2-4 No energy rich link
(ATP) DNP, amytal, atractylate. Also triggered by phenylsuccinate, and a-methyl required
glutamate (2)
Modification of the No modification of molecular weight of the "mobile AAT" as attested by gel No modification of
primary structure of electrophoresis on externalized, internalized and reexternalized 1251 enzyme* primary structure
mobile protein required
Modulation of chemical "Spontaneous" internalization of mitochondrial aspartate aminotransferase within Possible role of the
potential of interacting negatively charged liposomes as shown by latency of enzyme and inaccessibility modificatin of chemical
consitutants to protease digestion (6) potential
*Cr6mel, G., P. Hubert, and A. Waksman; data to be published.
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occur in situ and showed that succinate externalization of
AAT requires a more fluid membrane than for its internal-
ization. As a matter of fact, internalization still occurs at
temperatures below the thermotropic fusion point of the
membrane for the externalization of the enzyme.
This asymmetrical recognition of both the externalizing
signal and the molecule to be transitorily internalized was
also suggested by cross-linking experiments. After treating
mitochondria with dimethyladipimidate, externalization
of AAT was no longer triggered by succinate, whereas in
its absence, internalization of 70% of the enzyme still
occurred on cross-linked organelles. This suggests that a
greater rigidity or stability of the membrane could be
required for the recognition and integration of protein
signals as opposed to recognition of ionic signals (5). The
driving force of this protein movement seems to be depen-
dent on the chemical potential of both mobile protein and
membrane as modulated by environment rather than by
hydrolysis of an energy rich bond, or modification of the
primary structure of the mobile protein (Table II).
Configurational energy and cognitive properties could
thus be responsible for the externalization-internalization
phenomenon.
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FORMATION OF THE ENVELOPE OF ROUS SARCOMA
VIRUS AND VESICULAR STOMATITIS VIRUS FROM
LOCALIZED LIPID REGIONS IN THE PLASMA
MEMBRANE
GENEVA M. OMANN, JOSEPH CIMINO, JEFFREY E. PESSIN, AND MICHAEL GLASER
Department ofBiochemistry, University ofIllinois, Urbana, Illinois 61801 U.S.A.
The phospholipid polar head group composition of chicken
embryo fibroblasts and enveloped viruses grown on these
cells can be altered by supplementing the culture media
with polar head group analogues. Studies of the incorpora-
tion of analogues into host cell plasma membranes and
virus envelopes have shown that the viruses bud from
localized lipid regions which are different from the aver-
age composition of the plasma membrane (1). This selec-
tive incorporation of phospholipids into the virus envelope
may result from a specific requirement of the virus to
regulate the envelope membrane structure. To test this
hypothesis, the effects of altering the host cell plasma
membrane lipid composition and fluidity on the viral
envelope lipid composition and fluidity were determined.
Measurements were made with 1,6-diphenyl-1,3,5-hexa-
Dr. Pessin's current address is the J. W. Wilson Laboratory, Brown
University, Providence, Rhode Island 02912 U.S.A.
triene (DPH) as a probe of membrane structure and
fluidity using steady-state anisotropy methods and differ-
ential polarized phase fluorometry (2).
METHODS
Chicken embryo fibroblasts were cultured as previously described (3).
RSV-T5-infected cells growing at 41OC were split into fresh medium, and
half were incubated at 410C and half at 360C. After 32 h the medium
was changed, and viruses and cells were harvested 12 h later. Polar head
group modification of phospholipids was done on tertiary cultures using
previously described methods (1). Cells were infected for 12 h with VSV
(San Juan strain) and viruses and cells harvested after 36 h growth in
choline- or 1-2-amino- I -butanol-supplemented media. Virus purification,
plasma membrane isolation, and phospholipid analysis were done as
previously described (1). Membranes were labeled with DPH as
previously described (4).
RESULTS
RSV-T5 is a Rous sarcoma virus mutant which infects
cells and replicates equally well at 360C and 410C. At
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